Lobe Sciences Ltd. is a biopharmaceutical company with programs in neurology and hematology.
We focus on groundbreaking research for the treatment of rare diseases including Chronic Cluster Headache and Sickle Cell Disease.
Conjugated Psilocin (CP) is our newly patented chemical entity (NCE) being developed for Chronic Cluster Headache.
Altemia® is a medical food (MF) for inborn metabolism errors found in patients with Sickle Cell Disease.
As an innovative biopharmaceutical
company, novel treatments for rare diseases are inclusive of our focus. Our research and development entails creating new medicine for people suffering from Chronic Cluster Headache (CCH) and proprietary medical food, especially for children suffering from the pain caused by Sickle Cell Disease (SCD).
The two diseases we're focused on, CCH (also known as Suicide Headache) and SCD, is due to the lack of viable treatments currently available.
The associated pains from these two diseases are considered some of the most unbearable and unimaginable.
By addressing these two critically unmet needs, we aim to alleviate a mass suffering and foresee a market of immense growth potential.
